nach oben

Erschienen in:

05.04.2024 | Typ-2-Diabetes | DDG Praxisempfehlungen

Adipositas und Diabetes

verfasst von: Prof. Dr. med. Jens Aberle, Anne Lautenbach, Svenja Meyhöfer, Sebastian M. Meyhöfer, Markus Menzen, Lars Selig, Knut Mai, Matthias Blüher

Erschienen in: Die Diabetologie | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Auszug

Auf der Webseite der Deutschen Diabetes Gesellschaft (https://www.ddg.info/behandlung-leitlinien/leitlinien-praxisempfehlungen) befinden sich alle PDF zum kostenlosen Download. …

Lindström J, Louheranta A, Mannelin M et al (2003) The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3‑year results on diet and physical activity. Diabetes Care 26:3230–3236CrossRefPubMed

Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403CrossRefPubMed

Lean MEJ, Powrie JK, Anderson AS et al (1990) Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med 7:228–233CrossRefPubMed

Williamson DF, Thompson TJ, Thun M et al (2000) Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 23:1499–1504CrossRefPubMed

Wing RR, Bahnson JL, Bray GA et al (2010) Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the look AHEAD trial. Arch Intern Med 170:1566–1575PubMed

Eeg-Olofsson K, Cederholm J, Nilsson PM et al (2009) Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia 52:65–73CrossRefPubMed

Davies M, Aroda VR, Collins BS et al (2022) Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 45:2753–2786CrossRefPubMedPubMedCentral

Wang Z, Hoy WE (2004) Waist circumference, body mass index, hip circumference and waist-to-hip ratio as predictors of cardiovascular disease in Aboriginal people. Eur J Clin Nutr 58:888–893CrossRefPubMed

Pischon T, Boeing H, Hoffmann K et al (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359:2105–2120CrossRefPubMed

10.

Evert AB, Dennison M, Gardner CD et al (2019) Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care 42:731–754CrossRefPubMedPubMedCentral

11.

Churuangsuk C, Hall J, Reynolds A et al (2022) Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission. Diabetologia 65:14–36CrossRefPubMed

12.

Hansen TT, Astrup A, Sjödin AL et al (2021) Are dietary proteins the key to successful body weight management? A systematic review and meta-analysis of studies assessing body weight outcomes after interventions with increased dietary protein. Nutrients 13:3193CrossRefPubMedPubMedCentral

13.

Lean ME, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, clusterrandomised trial. Lancet 391:541–551CrossRefPubMed

14.

Gregg EW, Chen H, Wagenknecht LE et al (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308:2489–2496CrossRefPubMedPubMedCentral

15.

Nationale VersorgungsLeitlinie (NVL) Typ-2-Diabetes. 1. Aufl.

16.

Kay SJ, Fiatarone Singh MA (2006) The influence of physical activity on abdominal fat: a systematic review of the literature. Obes Rev 7:183–200CrossRefPubMed

17.

ElSayed NA, Aleppo G, Aroda VR et al (2023) on behalf of the American Diabetes Association Diabetes Care. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes—2023. Diabetes Care 46(Suppl. 01):S128–S139CrossRefPubMed

18.

Vilsbøll T, Christensen M, Junker AE et al (2012) Effects of glucagon-like peptide‑1 receptor agonists on weight loss: systematic review and metaanalyses of randomised controlled trials. BMJ 344:d7771CrossRefPubMedPubMedCentral

19.

Pi-Sunyer X, Astrup A, Fujioka K et al (2015) A Randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med 373:11–22CrossRefPubMed

20.

Wilding JPH, Batterham RL, Calanna S et al (2021) Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 384:989–1002CrossRefPubMed

21.

Rubino DM, Greenway FL, Khalid U et al (2022) Effect of weekly subcutaneous semaglutide vs daily Liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial. JAMA 327:138–150CrossRefPubMedPubMedCentral

22.

Rosenstock J, Wysham C, Frías JP et al (2021) Efficacy and safety of a novel dual GIP and GLP‑1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet 398:143–155CrossRefPubMed

23.

Frías JP, Davies MJ, Rosenstock J et al (2021) Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med 385:503–515CrossRefPubMed

24.

Jastreboff AM, Aronne LJ, Ahmad NN et al (2022) Tirzepatide once weekly for the treatment of obesity. N Engl J Med 387:205–216CrossRefPubMed

25.

Garvey WT, Frias JP, Jastreboff AM et al (2023) Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 402:613–626CrossRefPubMed

26.

Rubino F, Nathan DM, Eckel RH et al (2016) Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care 39:861–877CrossRefPubMed

27.

S3-Leitlinie: Chirurgie der Adipositas und metabolischer Erkrankungen. Version 2.3 (Februar 2018).

28.

Flum DR, Belle SH, King WC, Longitudinal Assessment of Bariatric Surgery (LABS) Consortium et al (2009) Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 361:445–454CrossRefPubMed

29.

Birkmeyer NJO, Dimick JB, Share D et al (2010) Hospital complication rates with bariatric surgery in Michigan. JAMA 304:435–442CrossRefPubMed

30.

Aberle J, Reining F, Dannheim V et al (2012) Metformin after bariatric surgery—An acid problem. Exp Clin Endocrinol Diabetes 120:152–153CrossRefPubMed

Titel: Adipositas und Diabetes
verfasst von: Prof. Dr. med. Jens Aberle
Anne Lautenbach
Svenja Meyhöfer
Sebastian M. Meyhöfer
Markus Menzen
Lars Selig
Knut Mai
Matthias Blüher
Publikationsdatum: 05.04.2024
Verlag: Springer Medizin
Schlagwörter: Typ-2-Diabetes
Adipositas
Adipositas
Bariatrische Chirurgie
Bariatrische Chirurgie
Tirzepatid
Semaglutid
Erschienen in: Die Diabetologie / Ausgabe 3/2024
Print ISSN: 2731-7447
Elektronische ISSN: 2731-7455
DOI: https://doi.org/10.1007/s11428-024-01169-x

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Kurz, prägnant und aktuell: Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft.

Zu den Praxisempfehlungen

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2024

Diabetische Retinopathie: Epidemiologie, Stadien, Diagnostik, Screening und Therapie

Einfluss der Remission des Typ-2-Diabetes auf das kardiovaskuläre und renale Risiko

Chirurgische Therapie der Adipositas

Diabetes, Sport und Bewegung

Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus

Langzeitergebnisse bariatrischer Chirurgie zur Therapie des Typ-2-Diabetes

Praxisempfehlungen der Deutschen Diabetes Gesellschaft